SCHEMBL18596389

SCHEMBL18596389

CC(C)(C)NC(=O)c1cccn(C(C)(C)C)c1=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
MET P08581 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KDM4E B2RXH2 3/20 0.39
POLB P06746 2/20 0.39
TP53 P04637 1/20 0.39
BRD4 O60885 2/20 0.38
BRD2 P25440 1/20 0.38
BRD3 Q15059 1/20 0.38
BRDT Q58F21 1/20 0.38
APEX1 P27695 1/20 0.37
ALDH1A1 P00352 4/20 0.36
GAA P10253 2/20 0.36
P2RX4 Q99571 1/20 0.36
GLA P06280 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12376659 0.82 MAPT (0.48) MAPTMEN1KMT2AMAOAMAOB
SCHEMBL20344700 0.81 MET (0.41) MEN1KMT2AMAOAMAOBMET
SCHEMBL11633601 0.80 ALDH1A1 (0.46) METSMN1; SMN2KDM4EPOLBAPEX1
SCHEMBL22210774 0.79 ALDH1A1 (0.47) MAPTKMT2AMETSMN1; SMN2KDM4E
SCHEMBL12376649 0.77 MAPT (0.47) MAPTMEN1KMT2AMAOAMAOB
SCHEMBL22210780 0.77 NPC1 (0.58) MAPTMEN1KMT2AMETSMN1; SMN2
SCHEMBL18596536 0.75 MAPT (0.42) MAPTMEN1KMT2AMAOAMAOB
SCHEMBL6748722 0.74 MAPT (0.61) MAPTMEN1KMT2AMAOAMAOB
SCHEMBL13101588 0.74 BRD4 (0.73) MAPTMEN1KMT2ASMN1; SMN2KDM4E
SCHEMBL12376654 0.74 MET (0.50) MEN1KMT2AMET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10208034-B2 Quinoline derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2019-02-19 US disclosed
US-20170349583-A1 QUINOLINE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2017-12-07 US disclosed
US-9586967-B2 Pyrrolo pyrimidine derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2017-03-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170349583-A1 QUINOLINE DERIVATIVE FLT3, AXL, ABL1 MAPT 2114/4885MEN1 441/4885KMT2A 369/4885
US-10208034-B2 Quinoline derivative FLT3, AXL, ABL1 MAPT 2114/4885MEN1 441/4885KMT2A 369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.